Bryan Garnier - HYDROGENPRO ASA (HYPRO) HydrogenPro: Q3 results, partnership with J.H.K.

Report

Bryan Garnier

Mahaut Arnaud ...

Paul de Froment
Thomas Mordelle

HydrogenPro: Q3 results, partnership with J.H.K.

HydrogenPro has reported Q3 2024 results confirming a slowdown in 2024 vs 2023 due to lacking and postponed investment decisions for green hydrogen production. With revenue of NOK72m in Q3 2024 (YTD NOK126m vs FY24 cons. at NOK252m) the group has been accelerating its Salzgitter Flachstahl project

12/11/2024 1 EN

Underlying

HYDROGENPRO ASA

See profile

NO0010892359 Norway

Provider

Bryan Garnier

Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.

See profile

Analysts

Mahaut Arnaud

Paul de Froment

Thomas Mordelle

Other Reports on these Companies

Bryan Garnier

HydrogenPro: slow pace in H1, waiting for new orders

HydrogenPro has reported Q2 2024 results confirming a slowdown compared to 2023. H1 2024 revenues came in at NOK54m vs NOK4m in Q1, significantly lower YoY (NOK221m in H1 2023) and 8% below cons. at NOK59m. Whereas a temporary reduction in activity was expected, transitioning from the completion of

August 20, 2024 August 20, 2024 1 EN

Bryan Garnier

HydrogenPro: Awaiting deliveries to Salzgitter and additional orders

Today, HydrogenPro reported Q1 2024 results which reflect slower activity than in previous quarters, with revenue of just NOK4m in Q1 2024 vs NOK83m in Q1 2023, NOK127m in Q4 2023 and cons. at NOK11m. As expected, revenues were impacted by the transition from the completion of ACES (US) and prepara

May 7, 2024 May 7, 2024 1 EN

Innate Pharma Q3 2024 update

Innate Pharma reported has reported Q3 2024 results, basically confirming unchanged cash reach to end-2025 on a net cash position at EUR96.4m exiting Q3 2024 (in-line with consensus) and 9M 2024 revenue at EUR10.2m (EUR8.3m in H1 2024).More importantly, the company provided an update on its pipelin

21h / 18m 21h / 18m 1 EN

Mahaut Arnaud ... (+3)

Mahaut Arnaud
Paul de Froment
Thomas Mordelle

Zaptec: soft Q3 revenue

This morning, Zaptec reported Q3 2024 results confirming a growth slowdown in 2024 compared to 2023 as the EV market pauses for breath, regulations mature and the company faces a negative base effect related to the Easee sales ban in 2023. Q3 revenue came in at NOK299m (-12% QoQ vs. NOK341m in Q2 2

21h / 21m 21h / 21m 1 EN

Aurelien Deside

Aurelien Deside

Exclusive Networks: EU clears the buyout

Following the buyout offer from Permira and CD&R, the EU cleared the transaction under Article 6(1)(b). As a reminder, Exclusive Networks received a buyout offer from majority owner Permira along with CD&R, for a consideration of EUR24.25 per share (EUR2.2bn), composed of both a EUR5.29 exc

21h / 30m 21h / 30m 1 EN

Sign-up for free to access full reports immediately

Email Address*

Choose Password* ( 6 or more characters )

Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.

Select your country*

Get financial insights straight to your inbox

By clicking "register" you accept the Terms and Conditions & Privacy Policy

Already on ResearchPool?

Almost there...

Are you a professional investor?

Select your country

REGISTER

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

In order to access this report please create an account.

LOGIN

HydrogenPro: Q3 results, partnership with J.H.K.

HydrogenPro: slow pace in H1, waiting for new orders

HydrogenPro: Awaiting deliveries to Salzgitter and additional orders

Innate Pharma Q3 2024 update

Zaptec: soft Q3 revenue

Exclusive Networks: EU clears the buyout

Create a free ResearchPool account to access full reports, get a personalised dashboard and follow providers or companies

Sign-up for free to access full reports immediately

ResearchPool Subscriptions

Get the most out of your insights

Why subscribe?

How to subscribe

ResearchPool Subscriptions

This report is only available to subscribers

Why subscribe?

How to subscribe